Tapinarof
1 NDC across 1 manufacturer|0 Generic,1 Brand
Tapinarof is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 23, 2022. In 2024, Medicare Part D spent $27 million on Tapinarof across 19,000 claims for 8,600 beneficiaries.
Tapinarof is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $25.25 to $25.25 per GM. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$25.25 – $25.25
per GM
7d Activity
avg -0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing TAPINAROF
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VTAMA 1% CREAM | $25.2486 per GM | -0.02% |
Frequently Asked Questions
What is Tapinarof used to treat?
Tapinarof is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Tapinarof?
In 2024, Medicare Part D spent $27 million on Tapinarof across 19,000 claims for 8,600 beneficiaries.
How many Tapinarof products are on the market?
The Tapinarof drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Tapinarof?
NADAC reference prices for Tapinarof range from $25.2486 to $25.2486 per GM.
Which manufacturers make Tapinarof?
1 manufacturer lists Tapinarof in NADAC. Ranked by number of NDCs, the largest are Organon LLC (1).
How has the price of Tapinarof changed recently?
Over the past 7 days, 0 Tapinarof NDCs rose and 1 fell, with a market-wide average change of -0.0%.